Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypomagnesemia and hypermagnesemia

Joel Michels Topf1, Patrick T Murray

  • 1University of Chicago, Chicago, IL 60615, USA.

Reviews in Endocrine & Metabolic Disorders
|May 27, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Admission Kidney Tubule Biomarkers Do Not Predict Acute Kidney Injury or In-Hospital Adverse Events in Acute Heart Failure.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Kidney tubule injury is associated with sodium avidity and diuretic responsiveness in acute heart failure.

ESC heart failure·2026
Same author

Discrepancy in Estimating GFR for Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant: A Retrospective Analysis.

Kidney360·2026
Same author

Corrigendum to "Early and Sensitive Detection of Cisplatin-Induced Kidney Injury Using Novel Biomarkers" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1175-1187].

Kidney international reports·2026
Same author

Comparative Performance of Novel and Standard Urinary Kidney Biomarkers for Prediction of Persistent Severe Acute Kidney Injury and Long-Term Major Adverse Kidney Events.

American journal of nephrology·2026
Same author

Factors associated with adverse haemodynamic events during the STARRT-AKI trial: a post-hoc secondary analysis.

Critical care (London, England)·2025